Danaher Co. (NYSE:DHR) Stock Holdings Reduced by Greenspring Advisors LLC

Greenspring Advisors LLC trimmed its position in shares of Danaher Co. (NYSE:DHR) by 13.2% in the 4th quarter, Holdings Channel reports. The institutional investor owned 1,155 shares of the conglomerate’s stock after selling 176 shares during the period. Greenspring Advisors LLC’s holdings in Danaher were worth $265,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. AMF Tjanstepension AB acquired a new stake in shares of Danaher in the third quarter valued at about $5,923,000. Czech National Bank grew its holdings in Danaher by 4.2% in the 3rd quarter. Czech National Bank now owns 130,939 shares of the conglomerate’s stock valued at $36,404,000 after buying an additional 5,320 shares during the last quarter. Diversified Trust Co increased its position in Danaher by 29.6% in the 3rd quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock worth $1,571,000 after buying an additional 1,289 shares during the period. Miracle Mile Advisors LLC acquired a new position in shares of Danaher during the third quarter worth approximately $310,000. Finally, Mather Group LLC. boosted its position in shares of Danaher by 9.2% in the third quarter. Mather Group LLC. now owns 8,931 shares of the conglomerate’s stock valued at $2,483,000 after acquiring an additional 749 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the subject of several research reports. Scotiabank assumed coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price for the company. KeyCorp boosted their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday. JPMorgan Chase & Co. lowered their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, UBS Group cut their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Stock Down 1.4 %

Shares of DHR opened at $211.92 on Thursday. The stock has a market capitalization of $153.07 billion, a PE ratio of 40.14, a P/E/G ratio of 2.80 and a beta of 0.83. Danaher Co. has a 12 month low of $210.04 and a 12 month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm’s 50 day moving average is $233.96 and its 200-day moving average is $252.39.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business earned $2.09 earnings per share. Equities research analysts forecast that Danaher Co. will post 7.77 EPS for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.51%. Danaher’s dividend payout ratio is currently 20.45%.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 10.90% of the stock is currently owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.